Possible Promise

Make Your Future Promise Possible

CF Industries Holdings, Inc. (NYS:CF)

Zacks Rank: 3 (Hold) [?]

Trade on Robinhood

CF Industries Holdings, Inc. engages in the manufacture and distribution of nitrogen fertilizer. The firm owns and operates nitrogen plants and serves agricultural and industrial customers through its distribution system. It operates through following segments: Ammonia, Granular Urea, UAN, AN, and Other. The Ammonia segment produces anhydrous ammonia, which is company's most concentrated nitrogen fertilizer product as it contains 82% nitrogen. The Granular Urea segment produces granular urea, which contains 46% nitrogen. The UAN segment produces urea ammonium nitrate solution, which is a liquid fertilizer product with a nitrogen content from 28% to 32%, is produced by combining urea and ammonium nitrate. The AN segment produces ammonium nitrate, which is a nitrogen-based product with a nitrogen content between 29% and 35%. The Other segment includes diesel exhaust fluid, nitric acid, urea liquor and aqua ammonia. The company was founded in 1946 and is headquartered in Deerfield, IL.

on Leave a Comment

Charlotte’s Web Holdings, Inc. (CWBHF) CEO Deanie Elsner on Q2 2020 Results – Earnings Call Transcript

Source: Seeking Alpha

Charlotte’s Web Holdings, Inc. (OTCQX:CWBHF) Q2 2020 Earnings Conference Call September 14, 2020 [08:30] AM ET Company Participants Cory Pala – Director of Investor Relations Deanie Elsner – Chief Executive Officer Russ Hammer – Chief Financial Officer Conference Call Participants Michael Lavery – Piper Sandler Gerald Pascarelli – Cowen Scott Fortune – ROTH Capital Partners Derek Dley – Canaccord Genuity Presentation Operator Ladies and gentlemen, thank you for standing by and welcome to the Charlotte’s Web Holdings Inc.

Read Full Article

on Leave a Comment

Sesen Bio to Present Regulatory and Business Development Update at the Canaccord Genuity 40th Annual Growth Conference

Source: Business Wire

CAMBRIDGE, Mass.–(BUSINESS WIRE)–August 5, 2020 – Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced it will be featured as a presenting company at the Canaccord Genuity 40th Annual Growth Conference on Thursday, August 13, 2020. The Company will provide an update on the regulatory process in the US and Europe, and the BD process outside the US. Event: Canaccord Genuity 40th Annual

Read Full Article

on Leave a Comment

Castlight Health’s (CSLT) CEO Maeve O’Meara on Q2 2020 Results – Earnings Call Transcript

Source: Seeking Alpha

Castlight Health, Inc. (NYSE:CSLT) Q2 2020 Earnings Conference Call July 28, 2020 [5:00] PM ET Company Participants Maeve O’Meara – Chief Executive Officer Will Bondurant – Chief Financial Officer Conference Call Participants Jeff Garro – William Blair & Company Charles Rhyee – Cowen Richard Close – Canaccord Genuity Gene Mannheimer – Colliers Securities Presentation Operator Good afternoon and welcome to the Castlight Health’s second quarter 2020 conference call.

Read Full Article